InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
2
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
-1.8%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by QUAY STEVEN C, Chief Executive Officer. Insider active across 2 companies, notably Atossa Therapeutics, INC.. In total, 5 filings have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €9k. Activity tracked since 21 May 2025. The latest transaction was filed on 27 March 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations5 total
65,000 shares0Common StockSEC:0001193125-26-134861:0
331,674 shares0Common StockSEC:0001193125-26-030571:0
331,674 shares0Common StockSEC:0001193125-26-030571
11,239 shares@ US$0.8797100.0% of flowCommon StockSEC:0000950170-25-076523:0
Ideal exit: 15 Feb 2026 (T+270)
50,000 sharesCommon StockSEC:0001144204-16-076463:0
Ideal exit: 15 Oct 2016 (T+270)
5 of 5 declarations
About QUAY STEVEN C
Steven C. Quay is the President and Chief Executive Officer at Atossa Therapeutics, Inc. He leads the company by defining the strategic vision and overseeing operations. His leadership is essential for the growth and success of Atossa.
